BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN)
1. BetterInvesting Magazine to feature Amgen as undervalued in August 2025 issue. 2. Amgen's fundamental review indicates potential investment interest from its undervaluation. 3. Editorial committee encourages deeper analysis for investors considering Amgen.